Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes.

@article{Hijazi2002ContributionOC,
  title={Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes.},
  author={Y. Hijazi and R. Boulieu},
  journal={Drug metabolism and disposition: the biological fate of chemicals},
  year={2002},
  volume={30 7},
  pages={
          853-8
        }
}
  • Y. Hijazi, R. Boulieu
  • Published 2002
  • Chemistry, Medicine
  • Drug metabolism and disposition: the biological fate of chemicals
    • Ketamine is a widely used drug for its anesthetic and analgesic properties; it is also considered as a drug of abuse, as many cases of ketamine illegal consumption were reported. Ketamine is N-demethylated by liver microsomal cytochrome P450 into norketamine. The identification of the enzymes responsible for ketamine metabolism is of great importance in clinical practice. In the present study, we investigated the metabolism of ketamine in human liver microsomes at clinically relevant… CONTINUE READING
    View PDF
    224 Citations
    Highly Influential Citations
    11
    Background Citations
    91
    Methods Citations
    3
    Results Citations
    3
    224 Citations
    Citation Type

    Citation Type

    Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
    • 28
    The CYP2B6*6 Allele Significantly Alters the N-Demethylation of Ketamine Enantiomers In Vitro
    • 33
    • Highly Influenced
    • PDF
    Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro.
    • 55
    In vitro evaluation of differences in phase 1 metabolism of ketamine and other analgesics among humans, horses, and dogs.
    • 30
    Role of Cytochrome P4502B6 Polymorphisms in Ketamine Metabolism and Clearance
    • 21
    Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    • 10
    Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes
    • 80
    Role of the equine CYP3A94, CYP3A95 and CYP3A97 in ketamine metabolism in presence of medetomidine, diazepam and methadone studied by enantioselective capillary electrophoresis.
    • 2
    Equine cytochrome P450 2B6--genomic identification, expression and functional characterization with ketamine.
    • 9
    Effects of medetomidine and its active enantiomer dexmedetomidine on N‐demethylation of ketamine in canines determined in vitro using enantioselective capillary electrophoresis
    • 16

    References

    SHOWING 1-10 OF 35 REFERENCES
    Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
    • 136
    • Highly Influential
    Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.
    • 252
    • PDF
    Use of heterologously expressed human cytochrome P450 1A2 to predict tacrine-fluvoxamine drug interaction in man.
    • 33
    Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
    • 375
    Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    • 152
    Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes.
    • 97
    • PDF
    Ketamine as a probe for medetomidine stereoisomer inhibition of human liver microsomal drug metabolism.
    • 45
    Metabolism of ketamine stereoisomers by human liver microsomes.
    • 119
    Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.
    • 222
    • PDF
    Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
    • 70